# ANI Pharmaceuticals to Present at Upcoming December Investor Conference

- Published: 2026-11-19
- Author: [ANI Pharmaceuticals, Inc.](https://biotechnews.io/news/ani-pharmaceuticals-to-present-at-upcoming-december-investor-conference.md)
- Press release: [Read the release](<https://www.globenewswire.com/news-release/2026/11/19/3406412/0/en/ani-pharmaceuticals-to-present-at-upcoming-december-investor-conference.html>)
- Topics: [News](https://biotechnews.io/news.md)
- Source: https://biotechnews.io/news/ani-pharmaceuticals-to-present-at-upcoming-december-investor-conference/
- Publication: Biotech News
- Publisher: Connectively (Terkel, Inc.)
- Editorial policy: https://biotechnews.io/editorial-policy/

PRINCETON, N.J., Nov. 19, 2026 [(GLOBE NEWSWIRE)](https://www.globenewswire.com) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company’s executive leadership team, will participate in a fireside chat at the following upcoming investor conference:

<table><tbody><tr><td>Event</td><td>Piper Sandler Healthcare Conference</td></tr><tr><td>Date</td><td>Tuesday, December 1, 2026</td></tr><tr><td>Time</td><td>12:30 p.m. ET</td></tr><tr><td>Webcast</td><td><a href="https://www.globenewswire.com/Tracker?data=Jpq2zpi1xX-6LKKQB8wiWoRcTMNMXeaHVFy7o3nujVPHjcjDM187hPWGD0tIhHMzijoYG4pEG8T4rl7CdlCyy4B1S9uvGANksf6cfVOqs2kdiyaGRbyyqxrBy93qSnDmNlHG5ZwKp4_QVFjrzPM0Iw==">Click here</a></td></tr><tr><td>&nbsp;</td><td>&nbsp;</td></tr></tbody></table>

The live and archived webcasts will also be accessible from the Company’s website at <a href="https://www.globenewswire.com/Tracker?data=gg6KQ5iKv4-FwZZAykbi2T77LqMV5VVRFA1K3WaQ_WrW557Ob6p8KARpS-i4sSdNt01wt7Qs2rXVVxZuBJErUCTnaFdgxo9tOLAoTUp6jnXKF6mz5ObwWOfAvrUOiSfNDZY5KNzQWe_5gK9NGif_EtS28CDI8OtieopBt-PjyE8HDB6-_0e66LEUTPIo61GtHsSub2iSrhXtbxqRBimkqGVn6Tb-ZyIcq4U5TymYU-i3cKWmodZfPUAX9z_zZGfVnmfiC7zVD9U3p1aI1xZGmEYXD4MxepmDNjJyHAt3vdo=" rel="nofollow">www.anipharmaceuticals.com</a>, in the Investors section under Events and Presentations.

**About ANI**

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of “Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit <a href="https://www.globenewswire.com/Tracker?data=nvJL2P005EcRLDirdgdx-Xr4MIJtl3sJOTbfqopZFospprdd74FCWGiOYaWtdWR5-d07yH9x3LUehnbA8-Lq1R1G6wspVNrWUsaH3RD5pdQt9JcBPBYqJgzkf3OSZhYzAanEUG6byVKaw2ScoNRytQ==" rel="nofollow">https://www.anipharmaceuticals.com.</a>

**Investor Relations:**  
Irina Koffler, Vice President, Investor Relations  
T: 917-734-7387  
E: Irina.koffler@anipharmaceuticals.com

**Media Relations:**  
Argot Partners  
T: 212-600-1494  
E: ani@argotpartners.com

*SOURCE: ANI Pharmaceuticals, Inc.*

  
![](https://ml.globenewswire.com/media/NTg1ZWZhMGItNjM5NS00MmQ4LTgyZTktYzIzZDczNjEwOWU3LTEwMzA4MzMtMjAyNi0xMS0xOS1lbg==/tiny/ANI-Pharmaceuticals-Inc-.png)

## Related

- [Breast milk's main whey protein is scarce in cow's milk. Three companies plan to brew it by fermentation](https://biotechnews.io/news/precision-fermented-alpha-lactalbumin-dyadic-brig-strive.md)
- [Why I Founded ZBIOME: Making Science-Backed Probiotics Accessible to All](https://biotechnews.io/insight/why-i-founded-zbiome-making-science-backed-probiotics-accessible-to-all.md)
- [Tarek El Ali, Founder, ZBIOME](https://biotechnews.io/interview/tarek-el-ali-founder-zbiome.md)
- [Dr. Jonathan Spages, Doctor, Author, Advanced Natural Health Center](https://biotechnews.io/interview/dr-jonathan-spages-doctor-author-advanced-natural-health-center.md)
